跳至主要内容
临床试验/IRCT20200405046958N1
IRCT20200405046958N1招募中2 期

Effect of Hydroxychloroquine on Novel Coronavirus Disease (COVID-19) prevention in cancer patients under treatment

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 no limit(—)
性别
All

入选标准

  • Patients with curable Acute Lymphoblastic Leukemia
  • Patients with curable Acute Myeloblastic Leukemia
  • Patients with curable high-grade non-Hodgkin Lymphoma
  • Patients with curable Breast cancer
  • Patients with curable Colon cancer
  • Age higher than 15 years

排除标准

  • Known sensitivity to Hydroxychloroquine
  • Weight lower than 35 kilograms
  • History of retinopathy
  • History of any cardiac disease
  • Acute respiratory tract infection in the last 2 month
  • Having novel Coronavirus in the first two weeks of entering the trial
  • Diabetes Mellitus
  • Immuno-suppressive disease other than cancer
  • Chronic pulmonary disease
  • Taking immuno-suppressive drugs other than cancer chemotherapy

研究者

相似试验